CYTOPIA RES PTY LTD has a total of 49 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ADVINUS THERAPEUTICS PRIVATE LTD, ASLANIAN ROBERT G and AMR TECHNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | United States | 8 | |
#3 | Brazil | 5 | |
#4 | China | 4 | |
#5 | Republic of Korea | 4 | |
#6 | South Africa | 4 | |
#7 | Canada | 3 | |
#8 | EPO (European Patent Office) | 3 | |
#9 | United Kingdom | 3 | |
#10 | Mexico | 2 | |
#11 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Climate change adaptation technologies | |
#7 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Burns Christopher John | 38 |
#2 | Wilks Andrew Frederick | 29 |
#3 | Bu Xianyong | 21 |
#4 | Zeng Jun | 16 |
#5 | Styles Michelle Leanne | 11 |
#6 | Feutrill John Thomas | 9 |
#7 | Kling Marcel Robert | 9 |
#8 | Harte Michael Francis | 8 |
#9 | Fantino Emmanuelle | 7 |
#10 | Treutlein Herbert Rudolf | 7 |
Publication | Filing date | Title |
---|---|---|
WO2009029998A1 | Retrometabolic compounds | |
WO2008092199A1 | Thiopyrimidine-based compounds and uses thereof | |
WO2008058341A1 | Inhibitors of kinase activity | |
WO2007062459A1 | Selective kinase inhibitors based on pyridine scaffold | |
US2009281119A1 | Acid addition salts of n-ethyi-n'-[2-methoxy-4-(5-methyi-4-pryimidin-2-yl)phenyl]urea and uses thereof | |
EP1899370A1 | A crystal structure and uses thereof | |
US2007128709A1 | Crystal structure of human Janus Kinase 2 (JAK2) and uses thereof | |
WO2005066156A1 | Selective kinase inhibitors | |
KR20060126981A | Azole-based kinase inhibitors | |
ZA200602138B | Azole-based kinase inhibitors |